PDS Biotechnology Corp Fair Value Adjustment of Warrants
PDS Biotechnology Corp (PDSB) reported Fair Value Adjustment of Warrants of $0 for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-18.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:FairValueAdjustmentOfWarrants · last filed 2021-03-18
- PDS Biotechnology Corp fair value adjustment of warrants for the quarter ending 2016-12-31 was $0.00.
- PDS Biotechnology Corp fair value adjustment of warrants for the quarter ending 2016-09-30 was $0.00, a 100.00% decline year-over-year.
- PDS Biotechnology Corp fair value adjustment of warrants for the quarter ending 2016-06-30 was $0.00, a 100.00% decline year-over-year.
- PDS Biotechnology Corp fair value adjustment of warrants for the quarter ending 2016-03-31 was $0.00, a 100.00% decline year-over-year.
- PDS Biotechnology Corp fair value adjustment of warrants for fiscal 2020 was $0.00, a 100.00% decline from fiscal 2019.
- PDS Biotechnology Corp fair value adjustment of warrants for fiscal 2019 was $81.70K.
- PDS Biotechnology Corp fair value adjustment of warrants for fiscal 2018 was $0.00.
- PDS Biotechnology Corp fair value adjustment of warrants for fiscal 2017 was $0.00.
| Period end | Fair Value Adjustment of Warrants | Fair Value Adjustment of Warrants 3 month | Fair Value Adjustment of Warrants 6 month | Fair Value Adjustment of Warrants 9 month | Fair Value Adjustment of Warrants 12 month |
|---|---|---|---|---|---|
| 2020-12-31 | $0.00 10-K · filed 2021-03-18 | ||||
| 2019-12-31 | $81.70K 10-K · filed 2021-03-18 | ||||
| 2019-03-13 | $81.70K 10-K · filed 2021-03-18 | ||||
| 2018-12-31 | $0.00 10-K · filed 2020-03-27 | ||||
| 2017-12-31 | $0.00 10-K · filed 2018-03-01 | ||||
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | $0.00 derived: sum of 2 quarters · filed 2018-03-01 | $0.00 derived: sum of 3 quarters · filed 2018-03-01 | $0.00 10-K · filed 2018-03-01 | |
| 2016-09-30 | $0.00 10-Q · filed 2016-11-01 | $0.00 derived: sum of 2 quarters · filed 2016-11-01 | $0.00 10-Q · filed 2016-11-01 | $0.00 derived: sum of 4 quarters · filed 2018-03-01 | |
| 2016-06-30 | $0.00 10-Q · filed 2016-08-03 | $0.00 10-Q · filed 2016-08-03 | $0.00 derived: sum of 3 quarters · filed 2018-03-01 | $1.43M derived: sum of 4 quarters · filed 2018-03-01 | |
| 2016-03-31 | $0.00 10-Q · filed 2016-05-03 | $0.00 derived: sum of 2 quarters · filed 2018-03-01 | $1.43M derived: sum of 3 quarters · filed 2018-03-01 | $1.78M derived: sum of 4 quarters · filed 2018-03-01 | |
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | $1.43M derived: sum of 2 quarters · filed 2018-03-01 | $1.78M derived: sum of 3 quarters · filed 2018-03-01 | $1.88M 10-K · filed 2018-03-01 | |
| 2015-09-30 | $1.43M 10-Q · filed 2016-11-01 | $1.78M derived: sum of 2 quarters · filed 2016-11-01 | $1.88M 10-Q · filed 2016-11-01 | $1.48M derived: sum of 4 quarters · filed 2017-03-02 | |
| 2015-06-30 | $350.13K 10-Q · filed 2016-08-03 | $446.32K 10-Q · filed 2016-08-03 | $47.78K derived: sum of 3 quarters · filed 2017-03-02 | -$41.52K derived: sum of 4 quarters · filed 2017-03-02 | |
| 2015-03-31 | $96.19K 10-Q · filed 2016-05-03 | -$302.35K derived: sum of 2 quarters · filed 2017-03-02 | -$391.64K derived: sum of 3 quarters · filed 2017-03-02 | ||
| 2014-12-31 | -$398.54K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-02 | -$487.84K derived: sum of 2 quarters · filed 2017-03-02 | -$582.36K 10-K · filed 2017-03-02 | ||
| 2014-09-30 | -$89.29K 10-Q · filed 2015-11-06 | -$183.82K 10-Q · filed 2015-11-06 | |||
| 2013-12-31 | $854.34K 10-K · filed 2016-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |